Takahiro Iino Selected Research

Takahiro Iino Research Topics

Disease

17	Neoplasms (Cancer) 03/2024 - 10/2007
12	Sarcoma (Soft Tissue Sarcoma) 04/2023 - 10/2007
8	Osteosarcoma (Osteogenic Sarcoma) 03/2024 - 06/2008
6	Osteoarthritis 08/2023 - 02/2009
5	Neoplasm Metastasis (Metastasis) 04/2023 - 06/2008
4	Reperfusion Injury 12/2021 - 11/2012
4	Ischemia 09/2019 - 11/2012
3	Inflammation (Inflammations) 12/2021 - 02/2010
3	Pain (Aches) 01/2020 - 07/2017
2	Breast Neoplasms (Breast Cancer) 10/2022 - 09/2018
2	Fibrosis (Cirrhosis) 01/2022 - 01/2021
2	Hyperuricemia 12/2021 - 07/2021
2	Necrosis 12/2021 - 01/2010
2	Body Weight (Weight, Body) 07/2021 - 01/2021
2	Wounds and Injuries (Trauma) 07/2020 - 02/2010
2	Hyperalgesia 01/2020 - 07/2017
2	Osteoporosis 11/2018 - 07/2017
1	Fibrosarcoma 04/2023
1	Foreign-Body Reaction 01/2022
1	Synovitis 12/2021
1	Atrophy 07/2021
1	Obesity 01/2021
1	Carcinogenesis 03/2020
1	Synovial Sarcoma (Synovioma) 04/2019
1	Esophageal Squamous Cell Carcinoma 04/2019
1	Testicular Neoplasms (Testicular Cancer) 04/2019
1	Melanoma (Melanoma, Malignant) 04/2019
1	Ganglion Cysts (Ganglion) 11/2018
1	Aneurysm (Aneurysms) 05/2018
1	Peripheral Nerve Injuries 05/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Hypersensitivity (Allergy) 01/2016
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2016
1	Edema (Dropsy) 03/2013

Drug/Important Bio-Agent (IBA)

5	Interleukin-6 (Interleukin 6)IBA 07/2021 - 01/2017
3	EdaravoneIBA 09/2019 - 03/2013
3	TenascinIBA 01/2018 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 06/2013 - 10/2007
2	MetalsIBA 01/2022 - 01/2016
2	Febuxostat FDA Link 12/2021 - 07/2021
2	CytokinesIBA 07/2021 - 09/2018
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2020 - 09/2018
2	Free RadicalsIBA 09/2019 - 03/2013
2	Diphosphonates (Bisphosphonates)IBA 11/2018 - 07/2017
2	Bone Morphogenetic Protein 7IBA 05/2018 - 12/2009
2	C-Reactive ProteinIBA 01/2017 - 02/2014
2	Messenger RNA (mRNA)IBA 06/2013 - 09/2012
2	Proteins (Proteins, Gene)FDA Link 09/2012 - 10/2007
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2011 - 01/2010
2	Acridine OrangeIBA 12/2011 - 01/2010
2	DecorinIBA 06/2008 - 10/2007
2	Extracellular Matrix ProteinsIBA 06/2008 - 10/2007
1	Indicators and Reagents (Reagents)IBA 03/2024
1	pazopanib FDA Link 03/2024
1	Syndecan-4IBA 08/2023
1	Bortezomib (Velcade)FDA Link 04/2023
1	TOR Serine-Threonine KinasesIBA 04/2023
1	Proteasome InhibitorsIBA 04/2023
1	Everolimus FDA Link 04/2023
1	LigandsIBA 09/2022
1	Immune Checkpoint ProteinsIBA 09/2022
1	VimentinIBA 01/2022
1	Drinking WaterIBA 07/2021
1	Conditioned Culture MediaIBA 07/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2021
1	A-factor (Streptomyces)IBA 01/2021
1	CollagenIBA 01/2021
1	tocilizumab (atlizumab)FDA Link 11/2020
1	rebamipideIBA 07/2020
1	Protective AgentsIBA 07/2020
1	B7-H1 AntigenIBA 01/2020
1	Teriparatide (Parathar)FDA Link 01/2020
1	EnzymesIBA 01/2020
1	Caspase 3 (Caspase-3)IBA 09/2019
1	AntigensIBA 04/2019
1	Calcitonin Gene-Related PeptideIBA 11/2018
1	Transient Receptor Potential ChannelsIBA 11/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2018
1	Monoclonal AntibodiesIBA 09/2018
1	Carbonic Anhydrase IXIBA 01/2018
1	NeuropeptidesIBA 07/2017
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 07/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2016
1	Cadherins (E-Cadherin)IBA 06/2013
1	AntioxidantsIBA 03/2013
1	Lipoxygenase (Lipoxygenase-1)IBA 03/2013

Therapy/Procedure

5	Therapeutics 03/2024 - 12/2011
3	Intra-Articular Injections 12/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 11/2020 - 12/2011
2	Ovariectomy (Oophorectomy) 01/2020 - 07/2017
2	Tourniquets 09/2019 - 03/2013
2	Intraperitoneal Injections 09/2019 - 03/2013
1	Radiotherapy 10/2022
1	Reoperation 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Anesthesia 09/2019
1	Immunotherapy 04/2019
1	Surgical Instruments (Clip) 05/2018
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2016